Quarterly report pursuant to sections 13 or 15(d)

Note 1 - Description of the Business and Liquidity (Details)

v2.4.0.8
Note 1 - Description of the Business and Liquidity (Details) (USD $)
 1 Months Ended 3 Months Ended 12 Months Ended
Mar. 31, 2014
Jan. 31, 2013
Mar. 31, 2014
Mar. 31, 2013
Dec. 31, 2013
Dec. 31, 2012
Note 1 - Description of the Business and Liquidity (Details) [Line Items]            
Retained Earnings (Accumulated Deficit) $ (70,122,200)   $ (70,122,200)   $ (72,752,602)  
Net Cash Provided by (Used in) Operating Activities     (1,359,118) (2,242,766) (7,777,931)  
Proceeds from Issuance of Private Placement 3,503,314 9,829,014        
Cash and Cash Equivalents, at Carrying Value 5,801,050   5,801,050 9,198,267 3,516,244 1,620,005
Boston Scientific Notes [Member]
            
Note 1 - Description of the Business and Liquidity (Details) [Line Items]            
Notes Payable Cancelled, Principal Amount $ 4,338,601   $ 4,338,601